about
Human ovarian reserve from conception to the menopauseOvarian hyperstimulation syndrome: pathophysiology, staging, prediction and preventionCreating a continuum of care: integrating obstetricians and gynecologists in the care of young cancer patientsFertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessmentAMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysisDistribution and responsiveness of rat anti-Müllerian hormone during ovarian development and VCD-induced ovotoxicity.Measurement of serum anti-Müllerian hormone concentration in female dogs and cats before and after ovariohysterectomy.Anti-Müllerian hormone and progesterone levels produced by granulosa cells are higher when derived from natural cycle IVF than from conventional gonadotropin-stimulated IVF.FOXL2 Is an Essential Activator of SF-1-Induced Transcriptional Regulation of Anti-Müllerian Hormone in Human Granulosa Cells.Reproductive capacity in iron overloaded women with thalassemia major.Serum anti-Müllerian hormone as a predictive marker of polycystic ovarian syndrome.Possible involvement of single nucleotide polymorphisms in anti-Müllerian hormone signaling pathway in the pathogenesis of early OHSS in Han Chinese women.Molecular cloning and characterization of amh and dax1 genes and their expression during sex inversion in rice-field eel Monopterus albus.Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism.Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood.Fertility potential in thalassemia major women: current findings and future diagnostic tools.Peripubertal changes in circulating antimüllerian hormone levels in girls.Prediction of metaphase II oocytes according to different serum Anti-Müllerian hormone (AMH) levels in antagonist ICSI cycles.Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).Serum Anti-Müllerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment.Anti-Müllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF.Anti-Müllerian hormone in women with polycystic ovary syndrome.The management of patients with polycystic ovary syndrome.Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study.Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.Effects of Resveratrol on Ovarian Morphology, Plasma Anti-Mullerian Hormone, IGF-1 Levels, and Oxidative Stress Parameters in a Rat Model of Polycystic Ovary Syndrome.Baseline AMH Level Associated With Ovulation Following Ovulation Induction in Women With Polycystic Ovary Syndrome.Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas.Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases.Serum AMH Level to Predict the Hyper Response in Women with PCOS and Non-PCOS Undergoing Controlled Ovarian Stimulation in ARTThe effect of different hormone therapies on anti-müllerian hormone serum levels in anovulatory women of reproductive age.Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.Is polycystic ovary syndrome an exception for reproductive aging?The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease.Intracycle variation in number of antral follicles stratified by size and in endocrine markers of ovarian reserve in women with normal ovulatory menstrual cycles.Bone geometry according to menstrual function in female endurance athletes.Anti-Mullerian hormone (AMH): what do we still need to know?Anti-Müllerian hormone levels before and after uterine artery embolization.c-JUN Dimerization Protein 2 (JDP2) Is a Transcriptional Repressor of Follicle-stimulating Hormone β (FSHβ) and Is Required for Preventing Premature Reproductive Senescence in Female Mice.Pregnancy following ovarian induction in a patient with premature ovarian failure and undetectable serum anti-Müllerian hormone.
P2860
Q21142673-6D7C7F0A-E917-475E-9056-9B488DAE4159Q26827593-D20B81D8-E23E-42CC-A669-58A338A4652FQ27009361-84F928ED-2885-4A98-9010-9F61CC75F863Q28077710-32065E37-0A75-480F-A522-CF2C732E3813Q28289118-115F1A11-E3C8-4ACA-B729-0A672038587AQ34209380-5AD523CC-2064-4098-B4C4-5AF34FE92860Q34215276-A9862360-FBC9-434D-93F2-1E007A5C1332Q34472471-8B592822-E82B-4A00-AC95-2C44AC970CF3Q34534140-AE49F588-0CD6-4218-B295-ACB412E46714Q35212404-C43CB01F-9FA9-4F09-B7C9-786D3FE13C23Q35560602-BD96B060-3EF7-4C0C-9474-E3AA05C1A6A5Q36095415-30B997E7-81C2-4548-A9D5-40FC7735A2A8Q36291277-ACACE530-48FC-4FBE-A66C-AD724467B8A9Q36381560-974F3DFC-445B-49B4-B16A-52FAB5DC7611Q36932515-AD9B05F0-133F-4A44-9500-B69D712ED784Q37357809-6C780265-6910-4D81-943F-B845CF617DBEQ37531205-6A92081F-D419-451B-B20E-7A91B9191646Q37605344-2D498379-D9B0-42D3-A174-42E7EEC4EB83Q37606149-BA38338B-DA8E-438D-A786-D9DCE7791033Q37622327-AD9EAF73-BC58-43AD-ADA8-5605581282BFQ37671819-54B902F7-B349-4E6E-A203-B60A95E6A6B5Q37885328-C3845CC2-9345-4575-873B-C919F2C4E115Q38229280-E5B1469D-4F4B-47F6-96AC-E049DFCD7853Q38677158-836F5ACF-B362-403D-9E75-3BB3BE45D5C7Q38938581-AAA89D6B-99CE-4D13-B9AE-CD7D40724B9BQ39041432-7BB85C63-84A2-4815-8613-974855550834Q39734053-56CD970B-6554-40F1-A4B1-3CBAC26E50CBQ39763050-E3685F80-068D-4B1B-9DDB-31DEC42ECFB1Q39888178-6697F7A6-BDB5-44D1-9F7A-50C518C1E0C4Q41626041-0CEB2780-57EF-4ACE-BB38-DFC70BE72EB9Q42471959-5752A004-BF8B-46AA-BF39-EFF37E32D5C9Q42488135-48D6EBB1-E9B9-4C53-BB81-3AB670858463Q43077067-D56E1C34-496C-428D-8754-9A9C8FB27738Q43519793-155AC1AC-6B3B-4488-8AB4-5BE0D5AD26BDQ44260474-5513658E-04AC-4DCE-8AEE-E7BC34EB6AFFQ45163871-F37A460C-FF43-4F09-85D5-F11F42157396Q45972242-E145ED96-C500-4F03-9778-C237B1ACD755Q45998026-4930FCF3-82E6-401A-9AEE-0FE0A9E85664Q46047922-E98169A1-BBC4-4219-90A1-AC97CB38A9AFQ46193678-3F78DBBB-2FD8-4CCB-AD95-3FF13390C6F0
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-Müllerian hormone and ovarian dysfunction.
@en
Anti-Müllerian hormone and ovarian dysfunction.
@nl
type
label
Anti-Müllerian hormone and ovarian dysfunction.
@en
Anti-Müllerian hormone and ovarian dysfunction.
@nl
prefLabel
Anti-Müllerian hormone and ovarian dysfunction.
@en
Anti-Müllerian hormone and ovarian dysfunction.
@nl
P2093
P1476
Anti-Müllerian hormone and ovarian dysfunction.
@en
P2093
Axel P N Themmen
Bart C Fauser
Frank J Broekmans
Jenny A Visser
Joop S E Laven
Simone L Broer
P304
P356
10.1016/J.TEM.2008.08.002
P577
2008-09-18T00:00:00Z